Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
27
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Stereotaxis
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Robotic Catheters And Digital Surgery Will Boost Adoption
Key Takeaways Expanding proprietary product portfolio, regulatory approvals, and digital platform integration position Stereotaxis for greater market adoption, recurring revenue, and margin improvement. Strategic investments in sales and multi-application platforms broaden market reach and support sustainable growth in volumes, earnings, and profitability.
View narrative
US$4.50
FV
36.0% undervalued
intrinsic discount
39.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 days ago
author updated this narrative
Full House Resorts
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
American Place Expansion And Chamonix Upgrades Will Drive Sustainable Momentum
Key Takeaways Strong property-level growth, operational improvements, and marketing innovation are driving revenue gains, improved margins, and increased customer engagement. Legalization trends and broader market reach position the company for sustained long-term growth in gaming and hospitality.
View narrative
US$4.75
FV
22.3% undervalued
intrinsic discount
8.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Clarus
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Global Outdoor Market Expansion Will Unlock Long-Term Value
Key Takeaways International expansion, product innovation, and rising global demand are positioning core brands for sustained revenue growth and higher average selling prices. Operational streamlining, cost reductions, and financial discipline are improving margins and providing flexibility for further investment and long-term earnings growth.
View narrative
US$4.25
FV
12.3% undervalued
intrinsic discount
3.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
ADC Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Clinical Trial Successes And Shifting Demographics Will Transform Oncology
Key Takeaways Strong clinical data and precision medicine strategies position the company for broader market adoption and increased revenues in expanding oncology segments. Cost-cutting measures and strategic partnerships are set to improve margins, extend cash runway, and reduce financial risk.
View narrative
US$8.20
FV
61.2% undervalued
intrinsic discount
38.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 days ago
author updated this narrative
FiscalNote Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Global Policy Intelligence Will Fuel Transition Amid Challenges
Key Takeaways Rising demand for policy intelligence, driven by regulatory complexity and digital transformation, is boosting contract values, customer retention, and recurring revenue potential. Strategic innovations, customer migration to new platforms, and financial restructuring are strengthening operational flexibility and paving the way for sustained growth and profitability.
View narrative
US$2.85
FV
82.0% undervalued
intrinsic discount
-4.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
9 days ago
author updated this narrative
NX Filtration
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
New Dutch Factory And OEM Partnerships Will Fuel Market Expansion
Key Takeaways The new factory in the Netherlands and strengthened OEM partnerships are set to significantly boost production, operational efficiency, and future revenue growth. Global sales expansion and innovative technology investments focus on water scarcity solutions, enhancing market penetration and bolstering NX Filtration's ESG reputation.
View narrative
€4.24
FV
17.6% undervalued
intrinsic discount
68.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
9 days ago
author updated this narrative
MediWound
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Advanced Wound Care Demand Will Unlock Global Opportunities
Key Takeaways Expanding manufacturing and favorable reimbursement shifts are expected to unlock suppressed product demand, boost sales, and improve gross margins. Diversification through ongoing clinical trials, new product launches, and public sector partnerships should reduce risk and strengthen long-term financial stability.
View narrative
US$30.67
FV
42.6% undervalued
intrinsic discount
34.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 days ago
author updated this narrative
Inventiva
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Phase III Trials Will Advance Lanifibranor For MASH Treatment
Key Takeaways Strategic focus on lanifibranor development, cutting other activities, and reducing workforce may improve net margins through operational efficiency. Key partnerships in Asia and financial strength ensure market penetration and support sustained investment, boosting future earnings potential.
View narrative
€6.20
FV
37.4% undervalued
intrinsic discount
66.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
9 days ago
author updated this narrative
a.k.a. Brands Holding
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Omnichannel Expansion And TikTok Trends Will Drive Global Impact
Key Takeaways Omnichannel expansion, social commerce growth, and international market entry are strengthening brand awareness and fueling recurring revenue and long-term growth prospects. Data-driven merchandising, supply chain flexibility, and strategic pricing are enhancing operating efficiency, earnings quality, and margin stability.
View narrative
US$20.50
FV
47.0% undervalued
intrinsic discount
4.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies